Year: 2026
Type: article
Abstract: Early and precise cancer diagnosis is crucial for effective treatment. MicroRNAs (miRNAs) are promising diagnostic targets, but translating their complex, multi-dimensional expression signatures into clinical practice remains challenging. Here, we develop a concise molecular comparator using relative expression levels of specific miRNA pairs. The miRpair-based strategy demonstrates superior diagnostic performance compared to methods relying on the absolute quantification of single miRNAs. For non-small cell lung cancer (NSCLC) diagnosis, we identify hsa-miR-148a-3p/hsa-miR-30d-5p as the optimal diagnostic pair from The Cancer Genome Atlas (TCGA) data, with an area under the curve (AUC) of 0.975. The silicon-based model achieves 90.3% accuracy in 93 clinical serum samples using quantitative analysis. We subsequently translate the comparator into a DNA-based molecular workflow via asymmetric polymerase chain reaction (PCR) and polymerase-assisted hybridization subtraction (PAH-Sub). This process performs threshold-based comparison of dual-miRNA relative abundance directly at the molecular level. Integration with catalytic hairpin assembly (CHA) amplification generates fluorescent diagnostic outputs. Validation with 40 clinical serum samples yielded 87.5% accuracy, demonstrating the feasibility of molecular-level implementation of the miRpair decision rule. This study represents a proof-of-concept evaluation for NSCLC diagnosis. Further validation in independent cohorts incorporating clinically relevant disease controls will be required to establish broader clinical specificity.
Source: Small
DOI: 10.1002/smll.76763
Authors: Jiajia Song(Conceptualization, Data curation, Investigation, Methodology, Project administration, Validation, Writing – original draft), Ruiting Liu(Methodology, Validation), Linguo Gu(Data curation, Formal analysis, Resources), Kemin Wang(Resources), Zhenkun Xia(Data curation, Resources), Qiuping Guo(Data curation, Formal analysis), Jin Huang(Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Awards: G3012197813, G7393773678
OpenAlex ID: W7236469108
